Preparation method of 4-chloro-2-methoxybenzenesulfonyl chloride
The method optimizes the synthesis of 4-chloro-2-methoxybenzenesulfonyl chloride by using lithium halogen exchange and milder oxidants, addressing cost and safety issues in existing methods, achieving a yield of 86% and suitability for industrial use.
Patent Information
- Application Number
- CN202310652146.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-05
- Publication Date
- 2024-12-06
AI Technical Summary
Existing methods for synthesizing 4-chloro-2-methoxybenzenesulfonyl chloride are costly due to the use of palladium catalysts and involve hazardous materials like chlorine, making them unsuitable for industrial production.
A method involving lithium halogen exchange with 1,2-dimethyl disulfide followed by a milder oxidant such as sulfonyl chloride to produce compound III, with a yield improvement from 53% to 86%, and using safer oxidants like DCDMH or sulfonyl chloride to produce compound I.
The new process significantly reduces production costs and enhances safety, making it suitable for industrial production with improved yields.
Smart Images

Figure CN119080647A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of pharmaceutical intermediate synthesis, and in particular to a method for preparing 4-chloro-2-methoxybenzenesulfonyl chloride. Background Art
[0002] 4-Chloro-2-methoxybenzenesulfonyl chloride is an important fragment in drug design, and its derivatives have high biological activity and are widely used in the fields of chemistry, chemical industry, and medicine. 4-Chloro-2-methoxybenzenesulfonyl chloride itself is also a very important pharmaceutical intermediate, which is widely used in the synthesis of raw materials targeting ribonucleotide reductase (WO2022187200 A1), anti-tumor targets such as GCN2 and PERK kinase (WO2022109001 A1), autoimmune and inflammatory diseases (CN 113912597 A), and TRPV4 (CN 109790116 B), a target related to various diseases such as pain, hereditary motor neuron disease, cardiovascular disease, glaucoma, and diabetes. In recent years, it has become one of the hot spots in the drug discovery stage to seek some screening drugs with good activity by connecting 4-chloro-2-methoxybenzenesulfonyl chloride to specific structures. Therefore, 4-chloro-2-methoxybenzenesulfonyl chloride is a very promising drug intermediate.
[0003]
[0004] CN 113912597A discloses the following synthesis method of 4-chloro-2-methoxybenzenesulfonyl chloride:
[0005]
[0006] This synthetic route uses 1-bromo-4-chloro-2-methoxybenzene (C1) as a raw material, catalyzed by a palladium catalyst under alkaline conditions, and reacts with benzyl mercaptan to obtain compound C2. In the second step, the C2 compound is oxidized by NCS to obtain a compound of formula I. The main problem with this route is that the cost of using Pd2(dba)3 palladium catalysis to react is high, which is not suitable for industrial workshop production; in addition, another patent CN 109790116 B reports a method for converting thioether into sulfonyl chloride by bubbling chlorine into a solution of thioether in formic acid and performing an oxidation reaction with C2 compound. In this method, the use of chlorine is dangerous and is not suitable for industrial mass production. It can be seen that it is of great significance to develop a new preparation method for 4-chloro-2-methoxybenzenesulfonyl chloride. Summary of the invention
[0007] Purpose of the invention: The purpose of the present invention is to overcome the problems of high cost, insufficiently mild conditions, and unsuitability for industrial production in the above-mentioned prior art process for preparing 4-chloro-2-methoxybenzenesulfonyl chloride (compound of formula I), and to provide an improved method for preparing 4-chloro-2-methoxybenzenesulfonyl chloride (compound of formula I). Step 1 of the method optimizes the synthesis method of the intermediate compound of formula III, greatly reduces the synthesis cost, and improves the product yield; and step 2 uses a milder oxidant, which reduces the reaction risk during industrial mass production, and is safe and efficient. The yield of the compound of formula III synthesized by the original process is only about 53%, and the yield can reach 86% after using the new process, which solves the problem of basic raw materials for this series of products, making its derivative products easier to develop and suitable for industrial production.
[0008] On one hand, the present invention provides a method for preparing a compound of formula III, comprising the following steps: dissolving a compound of formula II in an organic solvent 1, reacting with 1,2-dimethyl disulfide in the presence of a lithium halogen exchange reagent to generate a compound of formula III.
[0009]
[0010] Preferably, the lithium halogen exchange reagent is selected from one of n-butyl lithium, sec-butyl lithium or tert-butyl lithium.
[0011] Preferably, the molar ratio of the compound of formula II to 1,2-dimethyl disulfide and lithium halogen exchange reagent is in the range of 1:1 to 1.5:1 to 2.
[0012] Preferably, the organic solvent 1 is selected from one or more of THF or MTBE, and the amount used is 6 to 15 times the volume of the compound of formula II.
[0013] Preferably, the reaction temperature ranges from -90 to -70°C; and the reaction time is 0.5 to 1 hour.
[0014] In another aspect, the present invention provides a method for preparing Compound I, comprising:
[0015]
[0016] In the preparation of compounds of formula II to III, the lithium halogen exchange reagent is selected from one of n-butyl lithium, sec-butyl lithium or tert-butyl lithium; the organic solvent 1 is selected from one or more of THF or MTBE; the molar ratio of the compound of formula II to the lithium halogen exchange reagent and 1,2-dimethyl disulfide is in the range of 1:1 to 1.5:1 to 2; the amount of the organic solvent 1 is 5 to 15 times the volume of the compound of formula II; the reaction temperature is -90 to -70°C; and the reaction time is 0.5 to 1 hour;
[0017] In the preparation of the compound of formula III to the compound of formula I, the oxidant is selected from one of DCDMH or sulfonyl chloride; the acidic reagent is selected from one of acetic acid + water or hydrochloric acid; the organic solvent 2 is selected from one or more of DCM and acetonitrile; the molar ratio of the compound of formula III to the oxidant is in the range of 1:3 to 7; the reaction temperature range is -20 to 30°C; and the reaction time is 5 to 46 hours.
[0018] Preferably, in the preparation of the compound of formula II to the compound of formula III, the lithium halogen exchange reagent is n-butyl lithium; and the organic solvent 1 is MTBE.
[0019] Preferably, in the preparation of the compound of formula III to the compound of formula I, the oxidant is selected from sulfonyl chloride; and the molar ratio of the compound of formula III to the oxidant is in the range of 1:3.5-6.
[0020] Preferably, in the preparation of the compound of formula III to the compound of formula I, the acidic reagent is selected from acetic acid + water.
[0021] Preferably, in the preparation of the compound of formula III to the compound of formula I, the organic solvent 2 is selected from DCM, and the amount used is 8 to 12 times the volume of the compound of formula III.
[0022] Preferably, in the preparation of the compound of formula III to the compound of formula I, the reaction temperature ranges from 0 to 20° C. and the reaction time ranges from 5 to 40 hours.
[0023] The abbreviations of some reaction reagents involved in the present invention are as follows:
[0024] BnSH: benzyl mercaptan
[0025] Pd2(dba)3: tris(dibenzylideneacetone)dipalladium
[0026] Xanphos:4,5-bis(diphenylphosphino)-9,9-dimethylxanthene
[0027] DIEA: N,N-diisopropylethylamine
[0028] Toluene: Toluene
[0029] DCDMH: Dichlorohydantoin
[0030] DCM: dichloromethane
[0031] THF: Tetrahydrofuran
[0032] MTBE: Methyl tert-butyl ether
[0033] NCS: N-chlorosuccinimide
[0034] Beneficial Effects
[0035] The present invention provides a method for preparing 4-chloro-2-methoxybenzenesulfonyl chloride, which uses 1-bromo-4-chloro-2-methoxybenzene (compound of formula II) as a raw material, reacts with 1,2-dimethyl disulfide under the action of a lithium halogen exchange reagent to generate a compound of formula III; the compound of formula III undergoes an oxidation reaction with an oxidant in the presence of an acidic reagent to generate 4-chloro-2-methoxybenzenesulfonyl chloride (compound of formula I). Compared with the existing synthesis process, the new process optimizes the synthesis method of the compound of formula III, solves the problem of high cost of using palladium catalyst in the original synthesis route, the yield of the compound of formula III in the original process is about 60%, and the yield of this step in the new process can reach 94%. In the second step oxidation reaction, a more gentle, safe and efficient sulfonyl chloride is also selected as an oxidant to participate in the reaction, and the yield can also be maintained. The total yield of the improved process can reach 86%. In summary, the technical solution provided by the present invention has a good economic effect, greatly reduces the production cost, and is suitable for industrial production. BRIEF DESCRIPTION OF THE DRAWINGS
[0036] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings in the following description are some embodiments of the present invention.
[0037] Figure 1 For the final product of Example 1 of the present invention 1 H-NMR spectrum. DETAILED DESCRIPTION
[0038] The present invention is further illustrated below in conjunction with specific embodiments. The embodiments are implemented based on the technical solutions of the present invention. It should be understood that these embodiments are only used to illustrate the present invention and are not used to limit the scope of the present invention.
[0039] Example 1
[0040]
[0041] Preparation of compound of formula III:
[0042] In a 50L ultra-low temperature reactor, the compound of formula II (4kg, 18.06mol, 1eq.) was dissolved in MTBE (20.72kg), cooled to -80°C, and n-butyl lithium (1.27kg, 19.87mol, 1.1eq.) was added dropwise under controlled temperature. After the addition was completed, the mixture was stirred for 30min under the heat preservation condition. The temperature was controlled at -80°C, and 1,2-dimethyl disulfide (2.04kg, 21.66mol, 1.2eq.) was added dropwise. After the addition was completed, the mixture was reacted for 30min. After the reaction was completed by HPLC detection, the reactor was naturally warmed to 0°C, water (12kg) was added, the temperature in the reactor was controlled to be 0-20°C, the mixture was stirred, the liquid was separated, the organic phase was concentrated, and the mixture was distilled under reduced pressure to obtain 3.3kg of the product compound of formula III with a yield of 94.2%.
[0043] Preparation of compounds of formula I:
[0044] In a 50L reactor, water (1.36kg, 75.40mol, 4.1eq.), glacial acetic acid (4.53kg, 75.40mol, 4.1eq.), compound of formula III (3.47kg, 18.39mol, 1eq.), and DCM (45.98kg) were added, stirred to dissolve, cooled to 0-5°C, and sulfuryl chloride (10.17kg, 75.40mol, 4.1eq.) was added dropwise. After the temperature was controlled to be complete, the temperature was gradually returned to 20°C for reaction for 40h. HPLC detected that the reaction was complete, and the reaction solution was slowly poured into water (10.41kg*3) for washing, separated, the aqueous phase was discarded, the organic phase was combined, and a 5% sodium bicarbonate aqueous solution was added to the reactor to adjust the pH to 7-8, separated, the aqueous phase was discarded, and concentrated to obtain a crude product of 4-chloro-2-methoxybenzenesulfonyl chloride (compound of formula I). The crude product was added with n-heptane and ethyl acetate, the temperature was raised until the solution was clear, the temperature was gradually lowered to 0-5°C, filtered, and dried in vacuo to obtain 4.12 kg of the product 4-chloro-2-methoxybenzenesulfonyl chloride (compound of formula I), with a yield of 87.30%.
[0045] Comparative Experiment Example 1
[0046]
[0047] The above reaction route is an exploration of condition optimization based on the synthesis method of 4-chloro-2-methoxybenzenesulfonyl chloride (compound of formula I) disclosed in CN 113912597 A. The results are shown in Table 1-2.
[0048] Table 1 Optimization screening of reaction conditions for compound II to step IM1
[0049]
[0050]
[0051] Table 2 Optimization screening of reaction conditions from IM1 to compound of formula I
[0052]
[0053] Comparative Experiment Example 2
[0054]
[0055] Referring to the method of Example 1, screening tests were conducted on the reaction conditions of each step. The results are shown in Tables 3-5.
[0056] Table 3 Step 1 Experimental Condition Screening
[0057]
[0058] Table 4 Step 2 Reaction Condition Screening
[0059]
[0060] Table 5 Step 2 Reaction Time Optimization Screening
[0061]
[0062]
[0063] As can be seen from the examples, the preferred reaction conditions of the present application are the above-mentioned 4-chloro-2-methoxybenzenesulfonyl chloride (compound of formula I), the reaction conversion rate is high, the production cost is greatly reduced, and it is suitable for industrial production.
[0064] Although the above describes the specific implementation methods of the present invention, it is not intended to limit the scope of protection of the present invention. For ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principles of the present invention. These improvements and modifications should also be regarded as within the scope of protection of the present invention.
Claims
1. A method for preparing a compound of formula III, characterized in that The following steps are included: The compound of formula II is dissolved in an organic solvent 1, and reacts with 1,2-dimethyl disulfide under the action of a lithium halogen exchange reagent to generate a compound of formula III.
2. The preparation method according to claim 1, characterized in that: The lithium halogen exchange reagent is selected from one of n-butyl lithium, sec-butyl lithium or tert-butyl lithium.
3. The preparation method according to claim 1, characterized in that: The molar ratio of the compound of formula II to 1,2-dimethyl disulfide and lithium halogen exchange reagent is in the range of 1:1 to 1.5:1 to 2.
4. The preparation method according to claim 1, characterized in that: The organic solvent 1 is selected from one or more of THF or MTBE, and the amount used is 5 to 15 times the volume of the compound of formula II.
5. The preparation method according to claim 1, characterized in that: The reaction temperature range of the reaction is -90 to -70°C; the reaction time is 0.5 to 1 hour.
6. A method for preparing compound I, characterized in that The following steps are included: In the preparation of compounds of formula II to III, the lithium halogen exchange reagent is selected from one of n-butyl lithium, sec-butyl lithium or tert-butyl lithium; the organic solvent 1 is selected from one or more of THF or MTBE; the molar ratio of the compound of formula II to the lithium halogen exchange reagent and 1,2-dimethyl disulfide is in the range of 1:1 to 1.5:1 to 2; the amount of the organic solvent 1 is 5 to 15 times the volume of the compound of formula II; the reaction temperature is -90 to -70°C; and the reaction time is 0.5 to 1 hour; In the preparation of the compound of formula III to the compound of formula I, the oxidant is selected from one of DCDMH or sulfonyl chloride; the acidic reagent is selected from one of acetic acid + water or hydrochloric acid; the organic solvent 2 is selected from one or more of DCM and acetonitrile; the molar ratio of the compound of formula III to the oxidant is in the range of 1:3 to 7; the reaction temperature range is -20 to 30°C; and the reaction time is 5 to 46 hours.
7. The preparation method according to claim 6, characterized in that: In the preparation of the compound of formula II to the compound of formula III, the lithium halogen exchange reagent is n-butyl lithium; and the organic solvent 1 is MTBE.
8. The preparation method according to claim 6, characterized in that: In the preparation of the compound of formula III to the compound of formula I, the oxidant is selected from sulfonyl chloride; the molar ratio of the compound of formula III to the oxidant is in the range of 1:3.5-6.
9. The preparation method according to claim 6, characterized in that: In the preparation of the compound of formula III to the compound of formula I, the acidic reagent is selected from acetic acid + water.
10. The preparation method according to claim 6, characterized in that: In the preparation of the compound of formula III to the compound of formula I, the organic solvent is selected from DCM, and the amount used is 8 to 12 times the volume of the compound of formula III.
11. The preparation method according to claim 6, characterized in that: In the preparation of the compound of formula III to the compound of formula I, the reaction temperature ranges from 0 to 20° C. and the reaction time ranges from 5 to 40 hours.
Citation Information
Patent Citations
TRPV4 antagonist
CN109790116B
ROR[gamma] inhibitors, preparation method thereof and application thereof in medicine
CN113912597A
GCN2 and PERK kinase inhibitors and methods of use thereof
WO2022109001A1
Ribonucleotide reductase (RNR) inhibitors and uses thereof
WO2022187200A1
